Inke’s Key Insights from DDL 2024 – Shaping the Future of Inhalation APIs

From December 11th to 13th, 2024, Inke proudly participated in the 35th Annual Drug Delivery to the Lungs (DDL) conference held in Edinburgh, Scotland. As one of the most prestigious events in the field of respiratory medicine, DDL brought together industry leaders, researchers, and innovators to discuss the latest advancements in drug delivery technologies.

Located at Booth No. 204, Inke showcased our expertise in micronisation technology and respiratory APIs, engaging with visitors to highlight how our solutions are driving progress in the treatment of respiratory conditions. Our team enjoyed connecting with attendees, sharing insights, and exploring new opportunities for collaboration.

About DDL

DDL is a cornerstone event for the respiratory health community, fostering knowledge exchange and spotlighting cutting-edge innovations in pulmonary drug delivery. The conference features keynote speeches, scientific posters, and networking opportunities, making it an essential platform for shaping the future of respiratory medicine.

Thank You for Visiting Us!

We are grateful to everyone who stopped by our booth to learn more about Inke’s solutions. It was a pleasure to meet so many inspiring professionals and exchange ideas on improving patient outcomes through innovation.

If you missed us at DDL or want to learn more about Inke’s respiratory API portfolio, feel free to reach out at contact-inke@inke.es.

Let’s continue the conversation about transforming respiratory care together!